Male ICR Swiss mice (2 to 3 months old) were fed Candida albicans in their drinking water for 3 days, followed by no treatment, antibiotics in their drinking water (daily), or immunosuppressants given by intraperitoneal injection (two to three times weekly) over a 3-to 4-week period. The organs of animals were processed to determine the numbers of C. albicans and total aerobic bacteria per g of tissue. Untreated animals had mean Candida counts during the 1-month period of 102.3 CFU/g of cecum. Animals in six of eight antibiotic-treated groups had mean cecal Candida coun)ts higher than those of control animals (P < 0.05), with clindamycin-gentamicin producing the highest counts (104* CFU/g). Cyclophosphamide produced counts (104-3 CFU/g) which were higher (P < 0.05) than those resulting from methotrexate (103-°CFU/g) or steroid (102.7 CFU/g) treatment. Cyclophosphamide-clindamycin-gentamicin treatment was associated with the highest (P < 0.05) levels of Candida colonization (1065 CFU/g). Mice receiving immunosuppressants plus clindamycingentamicin were more likely to disseminate C. albicans than were mice receiving antibiotics alone (P < 0.001). Our findings suggest that colonization of the guts of mice by C. albicans can be facilitated by manipulating the aerobic, anaerobic, or both types of gut flora. The combiped effect of immunosuppressants on both Candida gut colonization and dissemination appears multifactorial and deserves further investigation.
Candida albicans is commonly found in the gastrointestinal (GI) tracts of humans (4) . The frequency of C. albicans isolation from stool varies (4, 7, 8) but is higher among immunosuppressed patients, particularly those with hematologic malignancies (2, 7). Eras et al. (7) found that 13% of 586 patients with myeloproliferative disease had histologically proven Candida infection of the GI tract as compared with 1.6% of patients with solid tumors. Antibiotic treatment has also been shown to increase the rate of C. albicans isolation in stool (15; M. Barza, M. Giuliano, and S. Gorbach, Program Abstr. 25th Intersci. Conf. Antimicrob. Agents Chemother., abstr. no. 1, 1985) .
Although uncommon in healthy individuals, C. albicans can disseminate from the GI tracts of humans (16) . The GI tract organ most commonly infected is the esophagus (7) , but other sites are also involved (4, 16, 20) . Guentzel and Herrera have demonstrated in immunosuppressed mice that gut C. albicans can disseminate to the liver, kidney, and other organs (9) . Kennedy and Volz have found that in Syrian hamsters pretreated with antibiotics, C. albicans can disseminate similarly (12) . Factors identified that facilitate this dissemination include suppression of the intestinal bacterial flora and high levels of Candida colonization in the gut (9, 12) .
As a first step toward understanding how C. albicans can invade and disseminate from the GI tract, we set out to develop a model of gut colonization. Many investigators have explored this question by using animal models in which the animals were exposed to C. albicans in a high-dose, bolus fashion with short-term follow-up (12, 17 18 ). Since such an approach can produce dissemination-of the organism in both animals and humans that are not immunocompromised (12, 13, 17, 18) , we felt that it might be more meaningful to develop a model in which each variable was monitored over a period of weeks rather than days or hours.
We examined in mice the effects of oral antibiotics, immunosuppressants, and combinations of both on quantitative colonization of the gut by C. albicans over 3-to 4-week periods. In (10 ml each) of this broth were then centrifuged at 400 x g for 10 min. The supernatant was decanted, and the pellet was washed three times in 10 ml of sterile, nonpyrogenic saline. The final saline-Candida mixture was stored in 1-ml aliquots at -70°C.
COLONIZATION AND DISSEMINATION OF C. ALBICANS 1559
Oral inoculation of C. albicans. C. albicans was given to each mouse by allowing it to drink the organism mixed with its drinking water for 3 days. The organism was prepared by taking 1 ml of the stock culture and proceeding as described for stock culture preparation. The final pellet of washed C. albicans was then added to deionized, autoclaved water (pH 5.5) and diluted to a concentration of approximately 2 x 106 CFU/ml. The exact concentration was determined by serial dilutions and surface plating on Sabouraud dextrose agar.
Specimen processing and enumeration of organisms. On each processing day (once or twice weekly), three or four mice in each experimental group were killed by cervical dislocation and dissected under aseptic conditions. Various organs (stomach, large and small intestines, cecum, liver, spleen, and kidney) were removed and weighed. The organs were ground in 2 to 4 ml of tryptic soy broth in sterile glass-glass tissue homogenizers (Ten Broeck Tissue Grinders; Fisher Scientific Co., Pittsburgh, Pa.). Serial dilutions of each homogenate were then plated on tryptic soy agar (Difco) and Sabouraud dextrose agar and incubated aerobically at 37°C. Blood was aspirated from the heart (0.5 to 1.0 ml) and pour plated with tryptic soy agar. Total aerobic bacteria (TAB) were counted after 24 h on tryptic soy agar; Candida colonies were counted after 48 h on Sabouraud dextrose agar plates. Identification of C. albicans was by colony morphology and Gram stain. C. albicans was easy to distinguish morphologically from bacteria because of its characteristic cream-colored colonies and the fact that none of the control animals (not fed C. albicans) had any detectable yeasts by our assay methods. This was true even for mice given tetracycline (data not shown).
Effects of antibiotics. Animals, after C. albicans inoculation, were fed antibiotics in their drinking water (deionized and autoclaved) for the duration of the experiment. The ceca of animals sacrificed at weekly intervals were processed for Candida and TAB counts. . Tetracycline was associated with slightly higher gut levels of C. albicans than the other antibiotics without affecting the TAB counts. This suggested that anaerobic bacteria might be more important than aerobic flora in preventing Candida colonization of the gut.
Therefore, we focused on antibiotics with substantial anaerobic activity (vancomycin, tetracycline, chloramphenicol [Parke, Davis & Co., Detroit, Mich.], and clindamycin [The Upjohn Co., Kalamazoo, Mich.]) in contrast to antibiotics with largely aerobic activity (gentamicin, trimethoprimsulfamethoxazole). Metronidazole was not studied because it had no detectable effect on C. albicans in the pilot study. The concentrations of antibiotics used were calculated on a weight basis to deliver the approximate dose that is used in humans for gut decontamination (vancomycin, 0.2 mg/ml; gentamicin, 0.1 mg/ml) (19) or the dose used parenterally for serious infections (tetracycline, 1 mg/ml; chloramphenicol, 0.5 mg/ml; clindamycin, 0.24 mg/ml; trimethoprim-sulfamethoxazole, 0.06 mg/ml of trimethoprim). This dosage was based on an approximate daily water consumption of 5 ml per mouse.
Effect of immunosuppressants alone. Immunosuppressive agents were given by intraperitoneal injection two or three times weekly at the following doses: cyclophosphamide RESULTS Effect of coprophagia on colonization of the GI tract with C. albicans. At 8 days after the 3-day oral C. albicans inoculation, mice housed in cages with wire mesh bottoms had lower Candida counts than did mice in solid-bottom cages (mean; log 2.0 versus 2.7 P < 0.05). Thereafter, the differences between the groups were not significant, but there was greater variation in Candida counts among mice housed in solid-bottom cages. For this reason, only data obtained from animals housed in wire mesh-bottom cages were reported (no data are displayed from the pilot antibiotic study).
Localization of C. albicans in the GI tract. Candida counts in the stomach, small intestine, cecum, and large intestine were compared (Fig. 1) . Except on day 8 of sampling, when the stomach counts were slightly lower than the cecal and large intestinal counts (P < 0.05), there were no differences among these four sample sites. For cantly higher Candida levels (P < 0.05). Vancomycin and trimethoprim-sulfamethoxazole had no effect when compared with untreated animals. An example of the changes in cecal Candida counts with time can be seen in Fig. 2 .
Striking differences were seen in the effects of antibiotics on cecal TAB counts. Tetracycline by itself had no detectable effect on TAB when compared with control animals (data not shown), although we cannot rule out counterbalancing effects on different organisms. In contrast, gentamicin resulted in a several-log drop in TAB (Fig. 3 ). Yet both of these drugs had similar effects on cecal Candida counts (Table 1 ). This suggests that modifying either the anaerobic or aerobic GI flora can facilitate Candida colonization. This consideration is further suggested by the finding that clindamycin and gentamicin together had an effect on cecal TAB that was significantly different from that of each drug individually (P < 0.05; Fig. 3) .
Effect of immunosuppressant alone on Candida GI colonization. Cyclophosphamide produced significantly higher Candida counts than those of all other groups (Fig. 4) Parallel with the cecal Candida findings, cyclophosphamide had the greatest effect on peripheral blood leukocyte counts (Table 2) . It produced lower total leukocyte, lymphocyte, and granulocyte counts than those of the methotrexate, steroid (methylprednisolone), or control group (P < 0.05).
Effects of antibiotics plus immunosuppressants on cecal Candida counts. The combination cyclophosphamide-clindamycin-gentamicin produced the highest cecal Candida counts observed in the whole study (Fig. 5 ) and was uniformly different from the clindamycin-gentamicin group (P < 0.05). The methotrexate and steroid (methylprednisolone)-antibiotic groups had Candida counts intermediate between those of the cyclophosphamide-antibiotic and antibiotic alone groups and were significantly different (P < 0.05) from the clindamycin-gentamicin group on only a single sample day. Mortality rates were 31% for the cyclophosphamide group, 12% for the methotrexate group, and 0%o for the steroid group.
Effects of antibiotics plus immunosuppressants on cecal aerobic bacterial counts. Immunosuppressants, in combination with clindamycin-gentamicin, had markedly different effects on cecal TAB counts as compared with the antibiotics alone (Fig. 6 ). On day 3 of the experiment, the cyclophosphamide-antibiotic regimen produced a peak in cecal TAB reached its nadir (105.7 CFU/g). The methotrexate and steroid groups produced intermediate effects. These findings suggest that the cytotoxic agents had an effect on the GI bacterial flora independent of those of antibiotics. Whether this was due to a direct effect on the bacteria or an indirect effect related to gut dysmotility and bacterial overgrowth is unknown at this time.
Dissemination of C. albicans versus bacteria. In spite of producing the highest levels of Candida colonization seen with antibiotics alone, the clindamycin-gentamicin group had almost no Candida dissemination (Table 3) . Candida dissemination was more common in the immunosuppressant plus antibiotic groups than in the antibiotic alone group (11/46 versus 1/23; P < 0.001). However, the steroid plus clindamycin-gentamicin group was the only immunosuppressant plus antibiotic combination that had significantly greater Candida dissemination than the antibiotic alone group (5/13 versus 1/23; P = 0.016). Bacterial dissemination occurred more frequently than Candida dissemination except in the steroid plus antibiotic group. This must be interpreted with caution because of the large number of mice not processed in the cyclophosphamide group because of death followed by rapid autolysis. C. albicans disseminated most commonly to the liver (8 mice; mean, 170 ± 340 [standard deviation] CFU/g of tissue), followed by kidney (5 mice; 370 ± 500 CFU/g) and spleen (3 mice; 400 ± 530 CFU/g). 
DISCUSSION
In our study, a combination of two antibiotics (clindamycin and gentamicin) was required to achieve high-level and prolonged colonization of the gut with C. albicans. Individually, clindamycin and gentamicin had an equal effect on Candida GI colonization (Table 1) . Gentamicin did this in association with a striking effect on the aerobic bacterial flora, whereas clindamycin had relatively little effect. In addition, tetracycline produced cecal Candida levels to similar to those produced by clindamycin and gentamicin without causing any detectable effect on the TAB. This suggests indirectly that the tetracycline effect on cecal C. albicans may be mediated through suppression of anaerobic bacteria. In combination, these data may indicate that the greater effect of the two-drug combination results from combined suppression of aerobic gram-negative rods by gentamicin and other organisms (probably including anaerobes) by clindamycin.
The only other study which longitudinally examined the effects of different antibiotics on Candida GI colonization was with humans. Barza et al. (25th ICAAC) found that in human volunteers given intravenous cefoperazone, cefoxitin, piperacillin, or aztreonam, cefoperazone produced the greatest fall in both anaerobic and aerobic stool bacterial counts. Cefoperazone also resulted in significantly higher stool C. albicans counts (P < 0.05) than did the other three drugs. These data support our hypothesis that both anaerobic and aerobic bacteria are likely to have an effect on Candida gut colonization.
It has been suggested by Kennedy and Volz (12) that the anaerobic bacterial gut flora is more important than aerobic bacteria at preventing Candida colonization and dissemination from the gut. In their hamster model, penicillin G reduced total gut anaerobic bacterial counts, increased facultative bacterial counts, and led to increased levels of C. albicans in the gut, with a high frequency of C. albicans dissemination to the liver, spleen, or kidney. A major concern about their conclusions, however, is that these findings were recorded only 24 h after three large intragastric inocula of C. albicans (107 organisms). Krause A nonlethal, leukopenia-producing dose of cyclophosphamide produced high-level, sustained colonization of the mouse cecum with C. albicans. Methotrexate and cortisol had no effect on C. albicans in comparison with untreated mice. Guentzel and Herrera (9), using mice colonized with C. albicans shortly after birth, reported that cyclophosphamide produced higher Candida levels than those in control animals 15 days after treatment was begun. Methotrexate resulted in higher levels 8 days after treatment was begun, and cortisone had a similar effect at 14 days. The lack of effect of methotrexate and cortisol in our model may be related to the possibility that the effects of these drugs on Candida colonization are small and short lived (days 7 to 14, Fig. 4 ) and that we did not detect them because we had only four animals in each experimental group. A more likely explanation is that it is due to the different colonization states achieved by the two models. In our model, with Candida inoculation into adult mice, sustained high-level colonization did not occur, whereas it did in the other model, in which mice were inoculated perorally as neonates (9) .
In parallel to the findings with immunosuppressants alone, addition of cyclophosphamide to clindamycin-gentamicin produced higher levels of Candida gut colonization than adding either methotrexate or steroid to the antibiotic treatment. Two factors that may contribute to this effect are the lower peripheral leukocyte counts (both granulocytes and (1, 11) . A more likely possibility may be that cyclophosphamide has a direct effect on the gut that brings about these changes. Although frank gut ileus has not been reported with cyclophosphamide, the drug is known to produce structural and functional changes in gut mucosal cells (3, 6, 10) . Thus, it is conceivable that bacterial and candidal overgrowth may occur in a manner similar to that seen with blind loops or dysmotility syndromes (5, 14) . Although steroids and methotrexate had relatively little effect in our model on cecal levels of C. albicans, they both had rates of Candida dissemination similar to those found with cyclophosphamide. This indicates that factors other than gut levels of C. albicans or peripheral leukocyte counts (or both) may be important determinants of whether C. albicans disseminates from the gut. Additional work is necessary to understand the combined effects of antibiotics plus immunosuppressants on Candida GI colonization and dissemination and its importance in the management of immunosuppressed patients.
